对人类SGLT的分子机制和计算洞察力:向选择性SGLT1抑制迈进
Nadhiri Kaijage1, Sebastian Kraszewski1
1Department of Biomedical Engineering, Faculty of Fundamental Problems of Technology, Wroclaw University of Science and Technology, Wroclaw, Poland.
Frontiers in molecular biosciences
|November 14, 2025
概括
选择性抑制-葡萄糖载体1 (SGLT1) 是治疗糖尿病和其他疾病的关键目标. 先进的计算方法与实验数据相结合,为开发SGLT1抑制剂提供了一个新的框架.
科学领域:
- 生物化学和结构生物学.
- 计算化学和药物设计.
背景情况:
- -葡萄糖运输体 (SGLTs) 对葡萄糖平衡至关重要.
- 虽然SGLT2抑制剂是已知的治疗方法,但选择性SGLT1抑制仍然是糖尿病,心血管疾病和癌症的未满足治疗需求.
研究的目的:
- 审查了解SGLT分子机制和抑制的最新进展.
- 通过整合计算和实验方法,提出开发选择性SGLT1抑制剂的框架.
主要方法:
- 电子显微镜 (cryo-EM) 和计算建模 (分子动力学模拟,自由能量计算,AlphaFold2预测).
- 同一性建模,3D-RISM水合分析,和具有约束力的自由能量计算.
- 通过突变发生和吸收/结合试验进行验证.
主要成果:
- 高分辨率结构揭示了抑制剂结合和构造动态.
- 发现了SGLT1和SGLT2之间的Na+位点占用率和封闭机制的差异.
- 经过实验验证的计算方法解释了合和构造转换.
结论:
- 结构和计算洞察力对于理解SGLT抑制至关重要.
- 利用SGLT1和SGLT2之间的结构差异是选择性的关键.
- 将AI/ML与实验数据相结合,为合理的SGLT1抑制剂设计提供了一个有希望的框架.
更多相关视频
相关概念视频
Glucose Transporters
27.1K
Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
27.1K
Secondary Active Transport
9.3K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
9.3K
Secondary Active Transport
136.6K
One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
136.6K
Glucose Absorption Into the Small Intestine
34.9K
Complex carbohydrates consumed cannot be absorbed into the small intestine in their original form. First, they must be hydrolyzed to a monosaccharide form such as glucose or galactose. These monosaccharides are then transported across the intestinal membrane and into the blood via transcellular transport. The intestinal epithelial cells allow the movement of these monosaccharides with a defined 'entry' through membrane transporter proteins present on their apical membrane and...
34.9K
The Significance of Membrane Transport
40.9K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
40.9K
Glucagon-like Receptor Agonists
828
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
828


